Search

everythinglearnresearchcommunity

for

Search:↓

Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Omega-6 fats in certain cells boost male hormone production.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Topical spironolactone effectively treats hair loss in women.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Topical spironolactone effectively treats hair loss in women.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Dissolvable microneedles with Ginsenoside Rg3 can help treat hair loss by improving drug delivery and stimulating hair growth.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.